MedTrace Logo

Functional MRI Biomarkers of Cognitive Decrements in Diabetes

NCT01705210 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2015-04-10

No results posted yet for this study

Summary

The exact neuronal mechanism underlying the cognitive decline associated with diabetes mellitus type 2 (DM2) still remains to be elucidated. Multi-parametric functional MRI can potentially provide functional, micro-structural, micro-vascular, and metabolic information on the affected brain at an earlier stage than does conventional structural MRI. The overall aim of the current proposal is to obtain a better understanding in the neuronal mechanisms that underlie cognitive decline in DM2 and the putative prediabetic condition the metabolic syndrome (MetS).

Conditions

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • Netherlands Organisation for Scientific Research

    collaborator OTHER_GOV

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Jacobus FA Jansen, PhD · Maastricht University Medical Center

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01705210 on ClinicalTrials.gov